Misbah Tahir insider trades

Open-market stock purchases and sales by Misbah Tahir, Chief Financial Officer at Maze Therapeutics, Inc, from SEC Form 4 filings since Feb 5, 2020.

Recent trades

DateStockTradeValue
Mar 2, 2026MAZE Maze Therapeutics, IncBought (not open market)—
Mar 2, 2026MAZE Maze Therapeutics, IncBought (not open market)—

Companies traded

  • MAZE Maze Therapeutics, Inc: other filings, last Mar 2, 2026
  • IGMS IGM Biosciences, Inc: 18 sales, last Jul 23, 2025

Get free alerts when Misbah Tahir files a new trade →